Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MDNA

Medicenna Therapeutics (MDNA) Stock Price, News & Analysis

Medicenna Therapeutics logo

About Medicenna Therapeutics Stock (NASDAQ:MDNA)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.16
$0.39
52-Week Range
N/A
Volume
1.27 million shs
Average Volume
160,047 shs
Market Capitalization
$10.93 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50
Consensus Rating
Buy

Company Overview

Receive MDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicenna Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

MDNA Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Medicenna’s MDNA11 Shows Promise in Cancer Treatment
See More Headlines

MDNA Stock Analysis - Frequently Asked Questions

Medicenna Therapeutics Corp. (NASDAQ:MDNA) announced its quarterly earnings results on Friday, November, 12th. The company reported ($0.12) earnings per share for the quarter, missing analysts' consensus estimates of ($0.09) by $0.03.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medicenna Therapeutics investors own include NVIDIA (NVDA), Broadcom (AVGO), CymaBay Therapeutics (CBAY), e.l.f. Beauty (ELF), Meta Platforms (META), Arista Networks (ANET) and AppLovin (APP).

Company Calendar

Last Earnings
11/12/2021
Today
7/12/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MDNA
CIK
1807983
Employees
16
Year Founded
N/A

Price Target and Rating

High Price Target
$2.50
Low Price Target
$2.50
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.60 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-42.68%
Return on Assets
-35.17%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.57
Quick Ratio
9.57

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.32 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
69,637,000
Free Float
46,587,000
Market Cap
$10.93 million
Optionable
Not Optionable
Beta
1.30
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:MDNA) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners